BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 25510142)

  • 1. [Risks associated with transfusions in sickle cell disease: delayed hemolytic transfusion reaction].
    Habibi A; Noizat-Pirenne F
    Rev Prat; 2014 Oct; 64(8):1128-9. PubMed ID: 25510142
    [No Abstract]   [Full Text] [Related]  

  • 2. How we treat delayed haemolytic transfusion reactions in patients with sickle cell disease.
    Gardner K; Hoppe C; Mijovic A; Thein SL
    Br J Haematol; 2015 Sep; 170(6):745-56. PubMed ID: 25967919
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Delayed haemolytic transfusion reaction in adults with sickle cell disease: a 5-year experience.
    Vidler JB; Gardner K; Amenyah K; Mijovic A; Thein SL
    Br J Haematol; 2015 Jun; 169(5):746-53. PubMed ID: 25753472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Delayed hemolytic transfusion reaction in sicle cell disease patients: a new challenge for the Hemovigilance network].
    Rieux C; De Meyer E; Boudjedir K
    Transfus Clin Biol; 2015 Mar; 22(1):37-41. PubMed ID: 25441454
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Unexpected Anemia and Reticulocytopenia in an Adolescent With Sickle Cell Anemia Receiving Chronic Transfusion Therapy.
    Blauel ER; Grossmann LT; Vissa M; Miller ST
    J Pediatr Hematol Oncol; 2015 Oct; 37(7):e438-40. PubMed ID: 26207780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic transfusion reaction after preoperative prophylactic blood transfusion for sickle cell disease in pregnancy.
    Proudfit CL; Atta E; Doyle NM
    Obstet Gynecol; 2007 Aug; 110(2 Pt 2):471-4. PubMed ID: 17666632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Delayed hemolytic reaction to transfusion in sickle cell anemia. Report of one case].
    Moya F; Rivera M; Araya F; Donoso J; Sandoval P; Varas P
    Rev Med Chil; 2018 Nov; 146(11):1347-1350. PubMed ID: 30725050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How I safely transfuse patients with sickle-cell disease and manage delayed hemolytic transfusion reactions.
    Pirenne F; Yazdanbakhsh K
    Blood; 2018 Jun; 131(25):2773-2781. PubMed ID: 29724898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preventing delayed hemolytic transfusion reactions in sickle cell disease.
    Castro O; Oneal P; Medina A; Onojobi G; Gordeuk VR
    Transfusion; 2016 Nov; 56(11):2899-2900. PubMed ID: 28211954
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed haemolytic transfusion reaction and hyperhaemolysis complicating peri-operative blood transfusion in sickle cell disease.
    McGlennan AP; Grundy EM
    Anaesthesia; 2005 Jun; 60(6):609-12. PubMed ID: 15918834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of delayed hemolytic transfusion reaction in sickle cell disease: Prevention, diagnosis, treatment.
    Pirenne F; Bartolucci P; Habibi A
    Transfus Clin Biol; 2017 Sep; 24(3):227-231. PubMed ID: 28669521
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extended phenotyping does not preclude the occurrence of delayed haemolytic transfusion reactions in sickle cell disease.
    Gerritsma J; Bongaerts V; Eckhardt C; Heijboer H; Nur E; Biemond B; van der Schoot E; Fijnvandraat K;
    Br J Haematol; 2022 Feb; 196(3):769-776. PubMed ID: 34632580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cause and pathogenesis of hemolytic transfusion reactions in sickle-cell disease.
    Pirenne F
    Curr Opin Hematol; 2019 Nov; 26(6):488-494. PubMed ID: 31589171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterizing complication risk from multisite, intermittent transfusions for the treatment of sickle cell disease.
    Tang A; Branscomb J; Zhou M; Snyder A; Eckman J
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27921. PubMed ID: 31318157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease.
    Cox JV; Steane E; Cunningham G; Frenkel EP
    Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed hemolytic transfusion reaction in adult sickle-cell disease: presentations, outcomes, and treatments of 99 referral center episodes.
    Habibi A; Mekontso-Dessap A; Guillaud C; Michel M; Razazi K; Khellaf M; Chami B; Bachir D; Rieux C; Melica G; Godeau B; Galacteros F; Bartolucci P; Pirenne F
    Am J Hematol; 2016 Oct; 91(10):989-94. PubMed ID: 27348613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fatal delayed transfusion reaction in a sickle cell anemia patient with Serratia marcescens sepsis.
    Seeyave D; Desai N; Miller S; Rao SP; Piecuch S
    J Natl Med Assoc; 2006 Oct; 98(10):1697-9. PubMed ID: 17052065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prophylactic red-cell transfusions in pregnant patients with sickle cell disease. A randomized cooperative study.
    Koshy M; Burd L; Wallace D; Moawad A; Baron J
    N Engl J Med; 1988 Dec; 319(22):1447-52. PubMed ID: 3054555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-s antibody-associated delayed hemolytic transfusion reaction in patients with sickle cell anemia.
    Kalyanaraman M; Heidemann SM; Sarnaik AP; Meert KL; Sarnaik SA
    J Pediatr Hematol Oncol; 1999; 21(1):70-3. PubMed ID: 10029818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood.
    Vichinsky EP; Earles A; Johnson RA; Hoag MS; Williams A; Lubin B
    N Engl J Med; 1990 Jun; 322(23):1617-21. PubMed ID: 2342522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.